Beta RBD boost broadens antibody-mediated protection against SARS-CoV-2 variants in animal models

Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) with resistance to neutralizing antibodies are threatening to undermine vaccine efficacy. Vaccination and infection have led to widespread humoral immunity against the pandemic founder (Wu-Hu-1). Against this bac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sheward, Daniel J., Mandolesi, Marco, Urgard, Egon, Kim, Changil, Hanke, Leo, Perez Vidakovics, Laura, Pankow, Alec, Smith, Natalie L., Castro Dopico, Xaquin, McInerney, Gerald M., Coquet, Jonathan M., Karlsson Hedestam, Gunilla B., Murrell, Ben
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536561/
https://www.ncbi.nlm.nih.gov/pubmed/34723224
http://dx.doi.org/10.1016/j.xcrm.2021.100450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536561/
https://www.ncbi.nlm.nih.gov/pubmed/34723224
http://dx.doi.org/10.1016/j.xcrm.2021.100450

Ejemplares similares